Suppr超能文献

MexXY-OprM 外排泵是铜绿假单胞菌对氨基糖苷类抗生素产生适应性耐药所必需的。

MexXY-OprM efflux pump is necessary for a adaptive resistance of Pseudomonas aeruginosa to aminoglycosides.

作者信息

Hocquet Didier, Vogne Christelle, El Garch Farid, Vejux Anne, Gotoh Naomasa, Lee Angela, Lomovskaya Olga, Plésiat Patrick

机构信息

Laboratoire de Bactériologie, Hôpital Jean Minjoz, Besançon, France.

出版信息

Antimicrob Agents Chemother. 2003 Apr;47(4):1371-5. doi: 10.1128/AAC.47.4.1371-1375.2003.

Abstract

Exposure of Pseudomonas aeruginosa to aminoglycosides frequently selects for recalcitrant subpopulations exhibiting an unstable, "adaptive" resistance to these antibiotics. In this study, we investigated the implication in the phenomenon of MexXY-OprM, an active efflux system known to export aminoglycosides in P. aeruginosa. Immunoblotting experiments demonstrated that the transporter MexY, but not the outer membrane pore OprM, was overproduced during the post-drug exposure adaptation period in wild-type strain PAO1. Furthermore, MexY production was dependent upon the degree of bacterial exposure to gentamicin (drug concentration). In contrast to parental strain PAO1, mutants defective in MexXY or in OprM were unable to develop adaptive resistance. Altogether, these results indicate that the resistance process requires the rapid production of MexXY and the interaction of these proteins with the constitutively produced component OprM.

摘要

铜绿假单胞菌暴露于氨基糖苷类药物时,常常会筛选出对这些抗生素表现出不稳定的“适应性”耐药的顽固亚群。在本研究中,我们调查了MexXY-OprM(一种已知可在铜绿假单胞菌中输出氨基糖苷类药物的活性外排系统)在该现象中的作用。免疫印迹实验表明,在野生型菌株PAO1的药物暴露后适应期,转运蛋白MexY而非外膜孔蛋白OprM过度产生。此外,MexY的产生取决于细菌接触庆大霉素的程度(药物浓度)。与亲本菌株PAO1不同,MexXY或OprM有缺陷的突变体无法产生适应性耐药。总之,这些结果表明,耐药过程需要快速产生MexXY以及这些蛋白质与组成型产生的组分OprM相互作用。

相似文献

1
MexXY-OprM efflux pump is necessary for a adaptive resistance of Pseudomonas aeruginosa to aminoglycosides.
Antimicrob Agents Chemother. 2003 Apr;47(4):1371-5. doi: 10.1128/AAC.47.4.1371-1375.2003.
2
[Mechanism of adaptive resistance to aminoglycosides of Pseudomonas aeruginosa].
Pathol Biol (Paris). 2003 Oct;51(8-9):443-8. doi: 10.1016/s0369-8114(03)00167-6.
3
Involvement of the MexXY-OprM efflux system in emergence of cefepime resistance in clinical strains of Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 2006 Apr;50(4):1347-51. doi: 10.1128/AAC.50.4.1347-1351.2006.
4
MexXY-OprM efflux pump is required for antagonism of aminoglycosides by divalent cations in Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 2001 Jul;45(7):2001-7. doi: 10.1128/AAC.45.7.2001-2007.2001.
7
Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1.
Antimicrob Agents Chemother. 2003 Mar;47(3):972-8. doi: 10.1128/AAC.47.3.972-978.2003.
8
Contribution of the MexX-MexY-oprM efflux system to intrinsic resistance in Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 2000 Sep;44(9):2242-6. doi: 10.1128/AAC.44.9.2242-2246.2000.
9
Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Antimicrob Agents Chemother. 2009 May;53(5):1987-97. doi: 10.1128/AAC.01024-08. Epub 2009 Mar 2.

引用本文的文献

1
The impact of aminoglycoside exposure on soil and plant root-associated microbiota: a meta-analysis.
Environ Evid. 2025 Jul 10;14(1):12. doi: 10.1186/s13750-025-00365-6.
2
Common regulatory mutation increases single-cell survival to antibiotic exposures in .
bioRxiv. 2024 Sep 22:2024.09.20.614194. doi: 10.1101/2024.09.20.614194.
4
Mechanism of antibacterial phytoconstituents: an updated review.
Arch Microbiol. 2024 Jun 24;206(7):325. doi: 10.1007/s00203-024-04035-y.
9
Berberine Derivatives as MexXY-OprM Inhibitors: Activity and In Silico Insights.
Molecules. 2021 Nov 2;26(21):6644. doi: 10.3390/molecules26216644.
10
In situ structure of the AcrAB-TolC efflux pump at subnanometer resolution.
Structure. 2022 Jan 6;30(1):107-113.e3. doi: 10.1016/j.str.2021.08.008. Epub 2021 Sep 9.

本文引用的文献

1
MexXY-OprM efflux pump is required for antagonism of aminoglycosides by divalent cations in Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 2001 Jul;45(7):2001-7. doi: 10.1128/AAC.45.7.2001-2007.2001.
2
Aminoglycoside adaptive resistance: importance for effective dosage regimens.
Drugs. 2001;61(6):713-21. doi: 10.2165/00003495-200161060-00001.
5
Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-oprM efflux pumps in Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 2000 Dec;44(12):3322-7. doi: 10.1128/AAC.44.12.3322-3327.2000.
6
Contribution of the MexX-MexY-oprM efflux system to intrinsic resistance in Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 2000 Sep;44(9):2242-6. doi: 10.1128/AAC.44.9.2242-2246.2000.
7
Characterization of a Pseudomonas aeruginosa efflux pump contributing to aminoglycoside impermeability.
Antimicrob Agents Chemother. 1999 Dec;43(12):2975-83. doi: 10.1128/AAC.43.12.2975.
8
Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides.
Antimicrob Agents Chemother. 1999 Nov;43(11):2624-8. doi: 10.1128/AAC.43.11.2624.
9
Small-colony variants of Pseudomonas aeruginosa in cystic fibrosis.
Clin Infect Dis. 1999 Sep;29(3):621-5. doi: 10.1086/598644.
10
Expression in Escherichia coli of a new multidrug efflux pump, MexXY, from Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 1999 Feb;43(2):415-7. doi: 10.1128/AAC.43.2.415.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验